A Study to Investigate Safety, Tolerability, and Pharmacokinetics of Tacabrutideg (BGB-16673) in Participants With Moderate and Severe Hepatic Impairment

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
The goal of this study is to understand how the body processes tacabrutideg in adults with different levels of liver function (normal, moderate impairment, and severe impairment).
Epistemonikos ID: c4e33d82e8a55beaa57d86d71b3bd08b63454b68
First added on: Oct 03, 2026